News
COO
354.49
-2.22%
-8.04
The Cooper Companies: Attractive If Management Can Pull Through
Seeking Alpha · 3d ago
Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Aptose Biosciences (APTO) and Praxis Precision Medicines (PRAX)
TipRanks · 4d ago
BRIEF-Cooper Companies Inc CEO Albert G. White III Annual Compensation Was $11.7 Million
Reuters · 4d ago
Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Seeking Alpha · 5d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 5d ago
Mizuho picks its top stocks for 2023
Seeking Alpha · 01/27 12:39
Mizuho Maintains Buy on Cooper Companies, Raises Price Target to $385
Benzinga · 01/24 12:47
Mizuho Adjusts Price Target on Cooper Companies to $385 From $375, Maintains Buy Rating
Mizuho Adjusts Price Target on Cooper Companies to $385 From $375, Maintains Buy Rating
MT Newswires · 01/24 09:56
What Does Cooper Companies' Debt Look Like?
Benzinga · 01/20 19:11
Hopeful Golden Cross Forms On Cooper Companies's Chart
Benzinga · 01/18 14:47
Analysts Offer Insights on Healthcare Companies: Cooper Co (COO) and Mettler-Toledo (MTD)
TipRanks · 01/18 02:10
The Latest Analyst Ratings for Cooper Companies
Benzinga · 01/11 21:00
Piper Sandler Maintains Overweight on Cooper Companies, Raises Price Target to $375
Benzinga · 01/11 14:48
Piper Sandler Adjusts Price Target on Cooper Companiesto $375 From $350, Maintains Overweight Rating
Piper Sandler Adjusts Price Target on Cooper Companiesto $375 From $350, Maintains Overweight Rating
MT Newswires · 01/11 10:44
Insider Sell: Cooper Companies
Insider Sell: Cooper Companies
MT Newswires · 01/10 16:44
Mizuho Initiates Coverage On Cooper Companies with Buy Rating, Announces Price Target of $375
Benzinga · 12/22/2022 12:00
Mizuho Initiates Cooper Companies With Buy Rating, Sets Price Target at $375
Mizuho Initiates Cooper Companies With Buy Rating, Sets Price Target at $375
MT Newswires · 12/22/2022 08:06
CooperCompanies Declares Cash Dividend
SAN RAMON, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, pay...
GlobeNewswire · 12/14/2022 21:15
CooperSurgical® partners with Ostro to educate consumers about Paragard® (intrauterine copper contraceptive)
CooperSurgical, Inc., a leader in women's healthcare, and Ostro, a leading engagement platform dedicated to educating and empowering consumers and healthcare providers, today announced their partnership to launch a new consumer engagement solution for Coop...
PR Newswire · 12/14/2022 19:41
--Cooper Companies Leaves Semi-Annual Dividend Unchanged at $0.03 a Share, Payable Feb. 10 to Holders of Record on Jan. 23
--Cooper Companies Leaves Semi-Annual Dividend Unchanged at $0.03 a Share, Payable Feb. 10 to Holders of Record on Jan. 23
MT Newswires · 12/14/2022 17:37
More
Webull provides a variety of real-time COO stock news. You can receive the latest news about Cooper through multiple platforms. This information may help you make smarter investment decisions.
About COO
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. CooperVision segment is engaged in developing, manufacturing and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision segment designs its products to solve vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigue, with a broad collection of spherical, toric and multifocal contact lenses. CooperSurgical segment focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women's health and fertility. CooperSurgical segment supplies the family health care market with a diversified portfolio of products and services. Its office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists.